Delivery Order SPE2DB22D3004-SPE2DB25FQF88

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,630.20 and an ultimate completion date of January 30, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,598,248 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $22,819.19 and runs through March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,908,804 units of Naloxone HCL 4 mg Nasal Spray 2s, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,437.31 and a completion date of April 15, 2025. It is a firm fixed-price contract with no set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone HCL 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a firm fixed price of $5,116.98 and a period of performance through April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $4,388.47 and runs through February 2025. There is no set-aside designation, indicating open competition for the award. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,287.20 and a completion date of February 25, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,008,836 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a ceiling value of $1,171.34 and a period of performance through April 24, 2025. This award is not set aside for any specific business category. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Naloxone Hydrochloride nasal spray. The contract has a ceiling value of $1,597.81 and a period of performance through January 8, 2024. It is a firm-fixed price contract, meaning the price is set and will not change. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.40, is for the delivery of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdose. The contract has a completion date of February 28, 2025 and was awarded on February 27, 2025 using a firm fixed-price pricing type. This delivery order is...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQF88
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Naloxone HCL 4 mg nasal spray, which is used to treat opioid overdoses. The total ceiling value of the contract is $12,453.28, and it runs through April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was competitively awarded.

Generated 7/11/25, 9:42 AM